SRDX - Surmodics FQ1 top line up 31%; earnings guidance raised January, 30 2019 04:53 PM Surmodics Inc. Surmodics (NASDAQ:SRDX) fiscal Q1 results (): Revenue: 22.2 (+30.6%); Medical Device: 17.3 (+35.2%). More news on: Surmodics, Inc., Healthcare stocks news, Earnings news and commentary, Read more ...